Zdrowie i gospodarka · 19/07/2007
FDA Clears Terbutaline Sulfate Injection for Approval
The FDA has determined that Brethine (Terbutaline Sulfate) Injection was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications for the medication.